Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
In API development, solid-state characterization analyzes the physical and chemical properties of the API in its solid form, a crucial step in formulation development. Meanwhile, crystallization process development ensures the creation of reliable crystalline structures, which is essential for safe and effective oral solid dose products.
Our new article features a Q&A with Thermo Fisher Scientific’s subject matter experts on the importance of solid-state characterization and crystallization process development, including why these processes should happen early on in drug development. It also explores how an end-to-end CDMO partner can help prevent delays and additional costs.